CT-1119

N/A

Report date: 2024/11/26 15:20:01

Base Information

Drug NameCT-1119

Drug Alias NameCT-119

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapy > Chimeric antigen receptor Monocyte Therapy

Mechanisms of ActionPhagocytes stimulantsImmunologic cytotoxicityMesothelin inhibitors +[4]

TargetsMesothelin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pennsylvania

China Registration ClassN/A

Develop Information

Active CompaniesCarisma Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A